Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on QiShen YiQi Dripping Pills for diabetic kidney disease assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QiShen YiQi Dripping Pills

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Diabetic Kidney Disease | Phase 2 | Status: UNKNOWN